Comparison of effect of adding Drakshavaleha to iron tablets in women with low Hemoglobin levels
- Conditions
- Health Condition 1: D509- Iron deficiency anemia, unspecified
- Registration Number
- CTRI/2024/05/067169
- Lead Sponsor
- Indian Council of Medical Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1 Women of reproductive age group (18 to 49 years) with mild (Hb 11-11.9) to moderate (Hb 8 to 10.9 g/dL) anemia
2 Serum ferritin less than 30 mcg/dL
3 Should consent to receive any type of intervention before randomization.
4 Not participating in any other research study
1 Pregnant and lactating women
2 Known cases of anemia due to other causes (Sickle cell anemia; Thalassemia minor)
3 Those who are already consuming IFA greater than 14 days
4 HbA1C greater than 6.5%
5 Known Diabetics on regular medicines
6 Known allergy to iron and ingredients of Drakshavaleha
7 Patient with known chronic kidney and liver disease
8 Any other condition in the advice of the treating doctor that is putting the participant on risk due to study participation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hb levelTimepoint: Baseline <br/ ><br>1 month <br/ ><br>2 months <br/ ><br>3 months
- Secondary Outcome Measures
Name Time Method quality-of-life score using Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) scaleTimepoint: Baseline <br/ ><br>3 months;Serum iron <br/ ><br>Total Iron binding capacity <br/ ><br>Ferritin <br/ ><br>Transferrin saturation <br/ ><br>RBC <br/ ><br>MCV <br/ ><br>MCH <br/ ><br>MCHCTimepoint: Baseline <br/ ><br>1 month <br/ ><br>2 months <br/ ><br>3 months